These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37963493)

  • 1. The impact of pseudoephedrine regulation at Australian pharmacies through Project Stop: A narrative review.
    Brookfield S; Gartner C
    Drug Alcohol Rev; 2024 Jan; 43(1):325-342. PubMed ID: 37963493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing community pharmacist engagement in a policing partnership strategy to reduce the illicit diversion of pseudoephedrine products.
    Webster JL
    Res Social Adm Pharm; 2013; 9(6):903-17. PubMed ID: 23548589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical sales of pseudoephedrine: the impact of electronic tracking systems on methamphetamine crime incidents.
    Mazerolle L; McGuffog I; Ferris J; Chamlin MB
    Addiction; 2017 Mar; 112(3):468-474. PubMed ID: 27741563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysing pseudoephedrine/methamphetamine policy options in Australia using multi-criteria decision modelling.
    Manning M; Wong GT; Ransley J; Smith C
    Int J Drug Policy; 2016 Jun; 32():85-92. PubMed ID: 27179610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linked electronic medication systems in community pharmacies for preventing pseudoephedrine diversion: a review of international practice and analysis of results in Australia.
    Berbatis CG; Sunderland VB; Dhaliwal SS
    Drug Alcohol Rev; 2009 Nov; 28(6):586-91. PubMed ID: 19930010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kentucky pharmacists' opinions of the potential reclassification of pseudoephedrine as a legend drug.
    Monson KE; Freeman PR; Goodin AJ; Talbert J; Blumenschein K
    J Am Pharm Assoc (2003); 2014; 54(4):397-405. PubMed ID: 25063261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing over-the-counter ephedrine and pseudoephedrine products to prescription only: impacts on methamphetamine clandestine laboratory seizures.
    Cunningham JK; Callaghan RC; Tong D; Liu LM; Li HY; Lattyak WJ
    Drug Alcohol Depend; 2012 Nov; 126(1-2):55-64. PubMed ID: 22592141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of pseudoephedrine pharmacy sales before and after mandatory recording requirements in Western Australia: a case study.
    Hattingh HL; Varsani J; Kachouei LA; Parsons R
    Subst Abuse Treat Prev Policy; 2016 Aug; 11(1):30. PubMed ID: 27577258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions.
    Cunningham JK; Liu LM
    Addiction; 2003 Sep; 98(9):1229-37. PubMed ID: 12930210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Online reporting of pseudoephedrine pharmacy sales: does Australia require a mandatory system?
    Devaney M; Ferris J; Mazerolle L
    Int J Pharm Pract; 2015 Aug; 23(4):248-255. PubMed ID: 25363467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impacts of federal precursor chemical regulations on methamphetamine arrests.
    Cunningham JK; Liu LM
    Addiction; 2005 Apr; 100(4):479-88. PubMed ID: 15784062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudoephedrine-Benefits and Risks.
    Głowacka K; Wiela-Hojeńska A
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recoveries of trace pseudoephedrine and methamphetamine residues from impermeable household surfaces: implications for sampling methods used during remediation of clandestine methamphetamine laboratories.
    Abdullah AF; Miskelly GM
    Talanta; 2010 Apr; 81(1-2):455-61. PubMed ID: 20188946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public stewardship of private for-profit healthcare providers in low- and middle-income countries.
    Wiysonge CS; Abdullahi LH; Ndze VN; Hussey GD
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD009855. PubMed ID: 27510030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The advent of a new pseudoephedrine product to combat methamphetamine abuse.
    Brzeczko AW; Leech R; Stark JG
    Am J Drug Alcohol Abuse; 2013 Sep; 39(5):284-90. PubMed ID: 23968171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment.
    Cunningham JK; Liu LM
    Soc Sci Med; 2008 Apr; 66(7):1463-73. PubMed ID: 18222587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Canadian federal methamphetamine precursor and essential chemical regulations on methamphetamine-related acute-care hospital admissions.
    Callaghan RC; Cunningham JK; Victor JC; Liu LM
    Drug Alcohol Depend; 2009 Dec; 105(3):185-93. PubMed ID: 19699042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.